FDA posed a sprawling set of questions for two-day gene therapy hearing. Here's what companies and experts will be watching for
Gene therapy is having a moment. Once confined to academic labs and a couple of companies, the field now encompasses hundreds of trials, dozens of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
